FDA warns that popular IV glutathione supplement caused sepsis-like reactions
The FDA has cautioned against using dietary-grade glutathione in IV form after more than 30 people experienced fever, chills and shock-like symptoms.
The Food and Drug Administration issued a warning this week after receiving more than 30 adverse event reports linked to intravenous glutathione marketed as a “master detoxifier.” Patients suffered fever, chills, dizziness, pain and signs of shock, with several needing hospitalization. The agency stressed that dietary supplement-grade glutathione, sourced from Medisca Inc. in Plattsburgh, NY, should not be used in compounded injectables because it may contain impurities such as endotoxins.
Compounding pharmacies in Texas have already initiated recalls due to high endotoxin readings. While the antioxidant is promoted for anti-aging benefits, research on its efficacy is scant and some studies suggest possible harm. The FDA continues to monitor reports and advises discontinuing use of the IV product. Dr. Andrew Steele cautioned that the supplement could be more detrimental than beneficial.
Why it matters
Consumers may be exposed to dangerous contaminants if they receive IV glutathione made from supplement-grade material.
In this story
